Trials / Unknown
UnknownNCT04215926
NAFLD in HIV-infected Patients
The Epidemiological Investigation and Pathogenesis of NAFLD in HIV-infected Patients: a Cross-sectional Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Shanghai Public Health Clinical Center · Other Government
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The prevalence of NAFLD (nonalcoholic fatty liver disease) in HIV-infected patients is higher than that in general population, but the causes of morbidity and pathogenesis have not been fully explored. The investigators are planning to consecutively enroll 400 cases HIV-positive outpatients, and to detect NAFLD by ultrasound. The fecal and blood samples were also collected to explore the mechanism of NAFLD. The investigators aimed to determine the prevalence and risk factors of NAFLD in HIV infected patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention; cross-sectional study | No intervention; cross-sectional study |
Timeline
- Start date
- 2019-12-05
- Primary completion
- 2020-10-30
- Completion
- 2020-11-30
- First posted
- 2020-01-02
- Last updated
- 2020-03-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04215926. Inclusion in this directory is not an endorsement.